NOTAS DE ENDODONCIA
APOYO
ACADÉMICO POR ANTOLOGÍAS
UNIDAD
14: ENDODONCIA PEDIÁTRICA
CONTENIDO GENERAL DEL CURSO | CONTENIDO DE LA UNIDAD | BIBLIOGRAFÍA DE ESTA SECCIÓN | ARTÍCULOS REVISADOS | PALABRAS CLAVE | SECCIONES: 1ª 2ª 3ª 4ª 5ª |
14.1. Generalidades de la endodoncia pediátrica 14.2. Anatomía dental y morfología pulpar de los dientes temporales. 14.2.1. Comparación con los dientes permanentes 14.2.2. Calcificación del ápice radicular
14.3. Terapéutica pulpar en dientes temporales 14.3.1. Indicaciones y contraindicaciones generales 14.3.1.1. Factores dentarios 14.3.1.2. Factores no dentarios 14.3.2. Recubrimientos pulpares 14.3.3. Pulpotomía con formocresol 14.3.3.1. Materiales 14.3.3.2. Técnicas 14.3.4. Pulpectomía 14.3.4.1. Indicaciones y contraindicaciones 14.3.4.2. Procedimientos
14.4. Tratamiento de dientes permanentes con ápice inmaduro 14.4.1. Dientes vitales con ápices abiertos (apicogénesis) 14.4.2. Dientes no vitales con ápices abiertos (apexificación) 14.4.2.1. Diferentes técnicas 14.5. Generalidades de la endodoncia geriátrica 14.5.1. Cambios histológicos pulpares por la edad 14.6. Historia Clínica General 14.6.1. Importancia en el paciente de la tercera edad 14.7. Historia Clínica dental 14.7.1. Diagnóstico 14.7.1.1. Vitalidad pulpar
14.7.2.1. Anestesia 14.7.2.2. Acceso 14.7.2.3. Preparación del conducto 14.7.2.4. Obturación 14.7.3. Reparación de los tejidos 14.8. Cirugía endodóntica 14.9. Restauración del diente
|
|
PALABRAS
CLAVE
|
|
|
IARC CLASSIFIES
FORMALDEHYDE AS CARCINOGENIC TO HUMANS |
"Twenty-six scientists from 10
countries evaluated the available evidence on the
carcinogenicity of formaldehyde, a widely used chemical",
reports Dr Peter Boyle, Director of the International Agency for
Research on Cancer (IARC), part of the World Health Organization.
The working group, convened by the IARC Monographs
Programme, concluded that formaldehyde is carcinogenic to
humans. Previous evaluations, based on the smaller number of
studies available at that time, had concluded that formaldehyde
was probably carcinogenic to humans, but new information
from studies of persons exposed to formaldehyde has increased
the overall weight of the evidence.
Based on this new information, the
expert working group has determined that there is now
sufficient evidence that formaldehyde causes nasopharyngeal
cancer in humans, a rare cancer in developed countries. "Their
conclusion that there is adequate data available from humans for
an increased risk of a relatively rare form of cancer (nasopharyngeal
cancer), and a supporting mechanism, demonstrates the value and
strengths of the Monographs Programme," emphasized Dr Boyle. The
working group also found limited evidence for cancer of
the nasal cavity and paranasal sinuses and "strong but not
sufficient evidence" for leukaemia. The finding for
leukaemia reflects the epidemiologists’ finding of strong
evidence in human studies coupled with an inability to identify
a mechanism for induction of leukaemia, based on the data
available at this time. "By signalling the degree of evidence
for leukaemia and cancer of the nasal cavity and paranasal
sinuses, the working group identified areas where further
clarification through research is needed. This represents a
service to Public Health", Dr Boyle concluded. Formaldehyde is produced
worldwide on a large scale. It is used mainly in the production
of resins that are used as adhesives and binders for wood
products, pulp, paper, glasswool and rockwool. Formaldehyde is
also used extensively in the production of plastics and coatings,
in textile finishing and in the manufacture of industrial
chemicals. It is used as a disinfectant and preservative (formalin)
in many applications. |
The IARC Monographs The IARC Monographs series publishes authoritative independent assessments by international experts of the carcinogenic risks posed to humans by a variety of agents, mixtures and exposures. Since its inception in 1972, the series has reviewed more than 880 agents, and IARC Monographs have become well-known for their thoroughness, accuracy and integrity. http://monographs.iarc.fr/. For details about evaluation criteria, please link to http://monographs.iarc.fr/ENG/Classification/index.php. For more information, please contact Dr Nicolas Gaudin, Chief, Communications, at com@iarc.fr or Dr Yann Grosse at grosse@iarc.fr |
World Health Organization
International Agency for Research on Cancer |
Organisation mondiale de la Santé
Centre international de Recherche sur le Cancer |
150, cours Albert-Thomas 69372 Lyon Cedex 08
(France)
Telephone: 33 472 738 485 Facsimile: 33 472 738 311 http://www.iarc.fr |
|
CONTENIDO GENERAL DEL CURSO | CONTENIDO DE LA UNIDAD | BIBLIOGRAFÍA DE ESTA SECCIÓN | ARTÍCULOS REVISADOS | PALABRAS CLAVE | SECCIONES: 1ª 2ª 3ª 4ª 5ª |